Zhejiang Huahai Sustainability Profile
Zhejiang Huahai Pharmaceutical Co., Ltd., commonly referred to as Huahai, is a prominent player in the global pharmaceutical industry, headquartered in Zhejiang, China. Founded in 1989, the company has established itself as a leader in the development and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms, particularly in the fields of cardiovascular and anti-infective medications. With a strong presence in both domestic and international markets, Huahai operates in various regions, including North America, Europe, and Asia. The company is renowned for its commitment to quality and innovation, boasting a diverse portfolio of products that meet stringent regulatory standards. Notable achievements include multiple certifications from global health authorities, positioning Huahai as a trusted supplier in the pharmaceutical sector.
DitchCarbon Score
How does Zhejiang Huahai's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Zhejiang Huahai's score of 27 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Zhejiang Huahai's reported carbon emissions
Zhejiang Huahai Pharmaceutical Co., Ltd., headquartered in China, has set ambitious climate commitments aimed at significantly reducing its greenhouse gas emissions. Although specific emissions data for the most recent year is not available, the company has established near-term targets through the Science Based Targets initiative (SBTi). Zhejiang Huahai commits to reducing its absolute Scope 1 and Scope 2 greenhouse gas emissions by 42% by 2030, using 2023 as the base year. Additionally, the company aims to achieve a 51.6% reduction in Scope 3 emissions per million CNY value added by 2030, with 2022 as the reference year. These targets align with the necessary reductions to limit global warming to 1.5°C, demonstrating the company's commitment to sustainable practices within the pharmaceuticals, biotechnology, and life sciences sector. Zhejiang Huahai's initiatives reflect a proactive approach to climate action, although it has not yet committed to a net-zero target. The company’s efforts are crucial in the context of the global push for reduced carbon emissions and enhanced corporate responsibility in combating climate change.
How Carbon Intensive is Zhejiang Huahai's Industry?
How Carbon Intensive is Zhejiang Huahai's Location?
Zhejiang Huahai's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Zhejiang Huahai has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
